TuesdayFeb 01, 2022 2:27 pm

Study Finds That Boosting T Cells May Improve Survival of Patients with Glioblastoma

New research has found that the combined use of radiation and IL-7 (interleukin 7), which is an immune-boosting protein, improves survival rates for mice with glioblastoma. Glioblastoma is a cancer that occurs in an individual’s spinal cord or brain. The conventional treatment for this fatal cancer is chemotherapy and radiation, with figures showing that only about 10% of patients survive for more than five years after being diagnosed with this aggressive cancer, which is resistant to new immunotherapies. The study was carried out by researchers at the School of Medicine at the Washington University in St. Louis. They found that…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050